About RABT Global — Your Trusted Regulatory Affairs Partner
Sub-headline: We are a leading life sciences regulatory consulting firm dedicated to simplifying regulatory complexity for pharmaceutical, medical device, and biotech companies across the globe.
Learn how RABT Global has been helping life sciences companies achieve global market access for over 15 years.
About RABT Global: we are a compliance-driven regulatory affairs consulting firm founded on the belief that expert regulatory guidance should be accessible, transparent, and effective. Since our establishment, RABT Global has grown into a trusted regulatory affairs partner for pharmaceutical, biotech, and medical device companies operating across the USA, EU, UK, India, and the Middle East.
Our team of experienced regulatory affairs professionals brings together specialists in FDA submissions, EMA regulations, MHRA compliance, CDSCO requirements, and GCC regulatory frameworks. We are not generalists — we are pharmaceutical and life sciences compliance experts who live and breathe regulatory affairs every day.
About RABT Global is a story of consistent growth driven by one thing: delivering results for our clients. From supporting a startup through its first FDA submission to managing a complex multi-market lifecycle programme for a global pharmaceutical group, RABT Global provides end-to-end regulatory consulting services that make the complex simple.
Our Journey — From Specialist Firm to Global Regulatory Partner
| Milestone | Achievement |
|---|---|
| Founded | Established with a core team of regulatory affairs specialists serving the pharmaceutical sector |
| First Expansion | Launched medical device regulatory services and EU authorised representative services |
| Middle East Entry | Opened regional operations to serve GCC pharmaceutical and device manufacturers |
| Asia-Pacific Growth | Extended CDSCO, TGA, and PMDA regulatory advisory capabilities |
| Today | 500+ successful submissions | 200+ global clients | 40+ countries covered |
The RABT Global Difference — Values That Drive Results
Expertise First
every engagement is led by qualified RA professionals, never passed to junior generalists
Transparency
clear timelines, honest feedback, and regular project updates from day one
Partnership Mindset
we act as an extension of your internal regulatory team, not just a vendor
Regulatory Intelligence
we stay ahead of regulatory changes so you don’t have to
Quality Without Compromise
every deliverable meets the highest regulatory and quality standards
Global Regulatory Strategy and Advisory — Where We Operate
| Region | Regulatory Coverage |
|---|---|
| United States | FDA — 21 CFR, 510(k), PMA, NDA, ANDA, IND submissions |
| United Kingdom | EMA — EU MDR, IVDR, CTD submissions, CE marking, EUDAMED |
| India | CDSCO — drug and device registration, clinical trial applications |
| Middle East (GCC) | SFDA (KSA), MOHAP (UAE), MOH Kuwait, Qatar MOPH — device & pharma |
About RABT Global — Common Questions
A: RABT Global combines qualified regulatory professionals, multi-jurisdictional expertise, and a genuine partnership approach. We are not a tickbox service — we take ownership of your regulatory programme and deliver results.
A: No. We work with organisations of all sizes — from early-stage biotech startups to global pharmaceutical groups. Our regulatory consulting for pharma and medical devices is scalable to your stage of growth and regulatory maturity.
A: Our services are structured around three core principles: end-to-end regulatory consulting services (full lifecycle coverage), global regulatory strategy and advisory (multi-market planning), and compliance-driven regulatory solutions (audit-ready deliverables every time).
Partner with RABT Global — Your Regulatory Affairs Experts
From your first submission to full lifecycle management, RABT Global is the end-to-end regulatory consulting services partner you can rely on.